drugset / Trial / NCT03991936
Benefit of Placebo and Different Concentrations of Triamcinolone Acetonide in Nail Psoriasis
RandomizedParallel-groupDouble-blindTreatment
Summary
This purpose of this study is to determine the lowest effective concentration of intralesional triamcinolone acetonide in the treatment of nail psoriasis.
Timeline
- Start
- 2020-03-11
- Primary completion
- 2023-03-29
- Completion
- 2023-03-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Triamcinolone Acetonide | Other / unclassified | 2.5 mg/ml | Other |
| Subject | Triamcinolone Acetonide | Other / unclassified | 5 mg/ml | Other |
| Subject | Triamcinolone Acetonide | Other / unclassified | 7.5 mg/ml | Other |
| Subject | Triamcinolone Acetonide | Other / unclassified | 10 mg/ml | Other |